ALS Strategy & Access Liaison

Otsuka America Pharmaceutical Inc.; Salt Lake City (UT); Remote; USD 158,000 - 252,000; Full time

Job summary

Otsuka America Pharmaceutical Inc. seeks a Strategic Account Liaison (SAL) to launch and grow the ALS program across the Rare Neurology Franchise. You will educate healthcare providers and ALS Centers of Excellence on disease state, screening, and access programs.

In this field-based role, you will engage with thought leaders, coordinate with market access teams, and help patients access therapies, while supporting ongoing product education and stakeholder alignment.

Qualifications

• Experience understanding complex disease states and articulating complex clinical data.
• Educate on disease state awareness, screening and diagnostic pathways.
• Develop and maintain relationships with HCPs and KOLs as a credible resource.
• Explain access and patient support programs to enable prescribing.
• Present at conferences and scientific meetings on rare neurology therapies.

Responsibilities

• Communicate clinical data, screening and treatment pathways to ALS Centers of Excellence and other stakeholders.
• Expand regional market access and patient support program understanding.
• Collaborate with cross-functional teams to drive ALS program launch and growth.
• Navigate hospital purchasing, reimbursement procedures, and site of care considerations.
• Pull through objectives by engaging with Market Access and Patient Support teams.

Skills

Clinical acumen

HCP engagement

KOL engagement

Access programs

Conferences

Education

Bachelor’s Degree

Job description

Otsuka America Pharmaceutical Inc. seeks a Strategic Account Liaison (SAL) to launch and grow the ALS program across the Rare Neurology Franchise. You will educate healthcare providers and ALS Centers of Excellence on disease state, screening, and access programs.

In this field-based role, you will engage with thought leaders, coordinate with market access teams, and help patients access therapies, while supporting ongoing product education and stakeholder alignment.